Global clinical trials are in a need of more efficient supply chain systems that can bring more transparency and risk mitigation strategies. Currently the clinical trial supply chain is following consumption based models which is very inefficient. They need to have better models which can take care of risk mitigation strategies as well. Rahul Sodhi of Beroe Inc. Looks into Drug Pooling in Clinical Trial Supply Chain.